Gg. Zhanel et al., DEVELOPMENT OF MULTIPLE-ANTIBIOTIC-RESISTANT (MAR) MUTANTS OF PSEUDOMONAS-AERUGINOSA AFTER SERIAL EXPOSURE TO FLUOROQUINOLONES, Antimicrobial agents and chemotherapy, 39(2), 1995, pp. 489-495
Laboratory-derived fluoroquinolone-resistant mutants were created by s
erially passaging wild-type Pseudomonas aeruginosa on fluoroquinolone-
containing agar to obtain high-level fluoroquinolone resistance (e.g.,
ciprofloxacin MIC of 1,024 mu g/ml). With increases of 4- to 32-fold
in MICs of fluoroquinolones, these organisms demonstrated (relative to
wild-type) normal morphology, resistance to fluoroquinolones only, no
change in fluoroquinolone uptake, and no change in lipopolysaccharide
profiles or outer membrane protein profiles. Complementation with wil
d-type Escherichia coli gyrA restored fluoroquinolone susceptibility,
suggesting that these were gyrA mutants. After 4- to 32-fold increases
in fluoroquinolone MICs (with continued passage on fluoroquinolone-co
ntaining agar) isolates demonstrated altered morphology, a multiple-an
tibiotic-resistant (Mar) phenotype (including cross resistance to beta
-lactams, chloramphenicol, and tetracycline), reduced fluoroquinolone
uptake and altered outer membrane proteins (reductions in the 25- and
38-kDa bands as well as several bands in the 43- to 66-kDa region). Co
mplementation with wild-type E. coli gyrA partially reduced the level
of fluoroquinolone resistance by approximately 8- to 32-fold, suggesti
ng that these mutants displayed both gyrA and non-gyrA mutations.